eFFECTOR Therapeutics Statistics
Total Valuation
EFTR has a market cap or net worth of $6.82 million. The enterprise value is $9.00 million.
| Market Cap | 6.82M |
| Enterprise Value | 9.00M |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
EFTR has 3.69 million shares outstanding. The number of shares has increased by 32.77% in one year.
| Shares Outstanding | 3.69M |
| Shares Change (YoY) | +32.77% |
| Shares Change (QoQ) | -11.49% |
| Owned by Insiders (%) | 3.63% |
| Owned by Institutions (%) | 17.91% |
| Float | 3.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.77
| Current Ratio | 0.77 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.27 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -160.00% |
| Return on Capital (ROIC) | -229.45% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.56M |
| Employee Count | 14 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.23% in the last 52 weeks. The beta is 0.52, so EFTR's price volatility has been lower than the market average.
| Beta (1Y) | 0.52 |
| 52-Week Price Change | -81.23% |
| 50-Day Moving Average | 9.75 |
| 200-Day Moving Average | 13.22 |
| Relative Strength Index (RSI) | 27.91 |
| Average Volume (30 Days) | 384,704 |
Short Selling Information
The latest short interest is 345,200, so 9.36% of the outstanding shares have been sold short.
| Short Interest | 345,200 |
| Short Previous Month | 318,066 |
| Short % of Shares Out | 9.36% |
| Short % of Float | 10.23% |
| Short Ratio (days to cover) | 1.54 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -33.84M |
| Pretax Income | -35.81M |
| Net Income | -35.81M |
| EBITDA | -32.78M |
| EBIT | -32.89M |
| Earnings Per Share (EPS) | -$16.37 |
Balance Sheet
The company has $18.37 million in cash and $20.55 million in debt, giving a net cash position of -$2.18 million or -$0.59 per share.
| Cash & Cash Equivalents | 18.37M |
| Total Debt | 20.55M |
| Net Cash | -2.18M |
| Net Cash Per Share | -$0.59 |
| Equity / Book Value | -5.80M |
| Book Value Per Share | -1.57 |
| Working Capital | -5.96M |
Cash Flow
In the last 12 months, operating cash flow was -$29.55 million and capital expenditures -$97,000, giving a free cash flow of -$29.65 million.
| Operating Cash Flow | -29.55M |
| Capital Expenditures | -97,000 |
| Free Cash Flow | -29.65M |
| FCF Per Share | -$13.56 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
EFTR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -32.77% |
| Shareholder Yield | -32.77% |
| Earnings Yield | -524.97% |
| FCF Yield | -434.61% |
Analyst Forecast
The average price target for EFTR is $112.17, which is 5,963.24% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $112.17 |
| Price Target Difference | 5,963.24% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 12, 2024. It was a reverse split with a ratio of 1:25.
| Last Split Date | Jan 12, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |